Concepedia

Nagarajan Elumalai

NE

8

Publications

216

Citations

8

H-Index

2015

Active since

Affiliations

Leipzig University(Current)

University of Southampton

AstraZeneca (United Kingdom)

Nagarajan Elumalai is an author at Leipzig University specializing in molecular biology, drug discovery, and signal transduction.

ORCID

Top concepts

Publications per year

2015–2023

8

Publications

8

Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a

Nagarajan Elumalai, Angela Berg, Kalaiselvi Natarajan et al. · Angewandte Chemie International Edition · 2015 · 63 citations · Full text

Rational development of Stafib-2: a selective, nanomolar inhibitor of the transcription factor STAT5b

Nagarajan Elumalai, Angela Berg, Stefan Rubner et al. · Scientific Reports · 2017 · 43 citations · Full text

Phosphorylation of Capsaicinoid Derivatives Provides Highly Potent and Selective Inhibitors of the Transcription Factor STAT5b

Nagarajan Elumalai, Angela Berg, Stefan Rubner et al. · ACS Chemical Biology · 2015 · 24 citations · Full text

, , +22

Inhibition of low-density lipoprotein receptor degradation with a cyclic peptide that disrupts the homodimerization of IDOL E3 ubiquitin ligase

Eilidh K. Leitch, Nagarajan Elumalai, Maria Fridén‐Saxin et al. · Chemical Science · 2018 · 22 citations · Full text

p53 promotes peroxisomal fatty acid β-oxidation to repress purine biosynthesis and mediate tumor suppression

Jianhong Zhao, Xiaojun Zhou, Baoxiang Chen et al. · Cell Death and Disease · 2023 · 21 citations · Full text

Rows per page

1–5 of 8